Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors

Kim Neve, Perry B. Molinoff

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

It is frequently hypothesized that drug-induced alterations in the density of β-adrenergic receptors underlie tolerance to and physical dependence on agonists and antagonists at β-adrenergic receptors. Two approaches to determining the effect of treatment with drugs on the density of β-adrenergic receptors are described. In the first, the density of β-adrenergic receptors was measured on leukocytes taken from human subjects during and after drug treatment. Treatment with the antagonist propranolol caused an increase in the density of β-adrenergic receptors on leukocytes, whereas treatment with the agonists terbutaline and ephedrine, or pindolol, an antagonist with intrinsic sympathomimetic activity, caused a decrease in the density of β-adrenergic receptors. In the second approach, the effect of agonists on the density of β-adrenergic receptors on C6 glioma cells in culture was determined. Incubation with the full agonist isoproterenol decreased the density of both β1 and β2-adrenergic receptors. In contrast, incubation with pindolol or celiprolol, also an antagonist with intrinsic sympathomimetic activity, selectively decreased the density of β2-adrenergic receptors. Pindolol and celiprolol may be useful in situations in which selective stimulation of β2-adrenergic receptors and blockade of β1-adrenergic receptors is desirable.

Original languageEnglish (US)
JournalThe American Journal of Cardiology
Volume57
Issue number12
DOIs
StatePublished - Apr 25 1986
Externally publishedYes

Fingerprint

Receptors, Adrenergic, beta
Adrenergic Receptors
Pindolol
Celiprolol
Sympathomimetics
Leukocytes
Pharmaceutical Preparations
Terbutaline
Ephedrine
Adrenergic Antagonists
Isoproterenol
Propranolol
Glioma
Cell Culture Techniques

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. / Neve, Kim; Molinoff, Perry B.

In: The American Journal of Cardiology, Vol. 57, No. 12, 25.04.1986.

Research output: Contribution to journalArticle

@article{40ec028f4279421aa46d6823eed4c084,
title = "Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors",
abstract = "It is frequently hypothesized that drug-induced alterations in the density of β-adrenergic receptors underlie tolerance to and physical dependence on agonists and antagonists at β-adrenergic receptors. Two approaches to determining the effect of treatment with drugs on the density of β-adrenergic receptors are described. In the first, the density of β-adrenergic receptors was measured on leukocytes taken from human subjects during and after drug treatment. Treatment with the antagonist propranolol caused an increase in the density of β-adrenergic receptors on leukocytes, whereas treatment with the agonists terbutaline and ephedrine, or pindolol, an antagonist with intrinsic sympathomimetic activity, caused a decrease in the density of β-adrenergic receptors. In the second approach, the effect of agonists on the density of β-adrenergic receptors on C6 glioma cells in culture was determined. Incubation with the full agonist isoproterenol decreased the density of both β1 and β2-adrenergic receptors. In contrast, incubation with pindolol or celiprolol, also an antagonist with intrinsic sympathomimetic activity, selectively decreased the density of β2-adrenergic receptors. Pindolol and celiprolol may be useful in situations in which selective stimulation of β2-adrenergic receptors and blockade of β1-adrenergic receptors is desirable.",
author = "Kim Neve and Molinoff, {Perry B.}",
year = "1986",
month = "4",
day = "25",
doi = "10.1016/0002-9149(86)90883-0",
language = "English (US)",
volume = "57",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors

AU - Neve, Kim

AU - Molinoff, Perry B.

PY - 1986/4/25

Y1 - 1986/4/25

N2 - It is frequently hypothesized that drug-induced alterations in the density of β-adrenergic receptors underlie tolerance to and physical dependence on agonists and antagonists at β-adrenergic receptors. Two approaches to determining the effect of treatment with drugs on the density of β-adrenergic receptors are described. In the first, the density of β-adrenergic receptors was measured on leukocytes taken from human subjects during and after drug treatment. Treatment with the antagonist propranolol caused an increase in the density of β-adrenergic receptors on leukocytes, whereas treatment with the agonists terbutaline and ephedrine, or pindolol, an antagonist with intrinsic sympathomimetic activity, caused a decrease in the density of β-adrenergic receptors. In the second approach, the effect of agonists on the density of β-adrenergic receptors on C6 glioma cells in culture was determined. Incubation with the full agonist isoproterenol decreased the density of both β1 and β2-adrenergic receptors. In contrast, incubation with pindolol or celiprolol, also an antagonist with intrinsic sympathomimetic activity, selectively decreased the density of β2-adrenergic receptors. Pindolol and celiprolol may be useful in situations in which selective stimulation of β2-adrenergic receptors and blockade of β1-adrenergic receptors is desirable.

AB - It is frequently hypothesized that drug-induced alterations in the density of β-adrenergic receptors underlie tolerance to and physical dependence on agonists and antagonists at β-adrenergic receptors. Two approaches to determining the effect of treatment with drugs on the density of β-adrenergic receptors are described. In the first, the density of β-adrenergic receptors was measured on leukocytes taken from human subjects during and after drug treatment. Treatment with the antagonist propranolol caused an increase in the density of β-adrenergic receptors on leukocytes, whereas treatment with the agonists terbutaline and ephedrine, or pindolol, an antagonist with intrinsic sympathomimetic activity, caused a decrease in the density of β-adrenergic receptors. In the second approach, the effect of agonists on the density of β-adrenergic receptors on C6 glioma cells in culture was determined. Incubation with the full agonist isoproterenol decreased the density of both β1 and β2-adrenergic receptors. In contrast, incubation with pindolol or celiprolol, also an antagonist with intrinsic sympathomimetic activity, selectively decreased the density of β2-adrenergic receptors. Pindolol and celiprolol may be useful in situations in which selective stimulation of β2-adrenergic receptors and blockade of β1-adrenergic receptors is desirable.

UR - http://www.scopus.com/inward/record.url?scp=0022499270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022499270&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(86)90883-0

DO - 10.1016/0002-9149(86)90883-0

M3 - Article

VL - 57

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -